GO:0090079 | translation regulator activity, nucleic acid binding | 9.88% (8/81) | 5.43 | 0.0 | 0.0 |
GO:0045182 | translation regulator activity | 9.88% (8/81) | 5.43 | 0.0 | 0.0 |
GO:0008135 | translation factor activity, RNA binding | 9.88% (8/81) | 5.43 | 0.0 | 0.0 |
GO:0006164 | purine nucleotide biosynthetic process | 8.64% (7/81) | 5.53 | 0.0 | 0.0 |
GO:0072522 | purine-containing compound biosynthetic process | 8.64% (7/81) | 5.38 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 13.58% (11/81) | 3.75 | 0.0 | 0.0 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 11.11% (9/81) | 4.25 | 0.0 | 0.0 |
GO:0006163 | purine nucleotide metabolic process | 8.64% (7/81) | 5.0 | 0.0 | 0.0 |
GO:0009165 | nucleotide biosynthetic process | 8.64% (7/81) | 4.94 | 0.0 | 0.0 |
GO:1901293 | nucleoside phosphate biosynthetic process | 8.64% (7/81) | 4.94 | 0.0 | 0.0 |
GO:0072521 | purine-containing compound metabolic process | 8.64% (7/81) | 4.89 | 0.0 | 0.0 |
GO:0003743 | translation initiation factor activity | 7.41% (6/81) | 5.48 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 23.46% (19/81) | 2.33 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 23.46% (19/81) | 2.2 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 23.46% (19/81) | 2.19 | 0.0 | 0.0 |
GO:0009117 | nucleotide metabolic process | 8.64% (7/81) | 4.45 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 23.46% (19/81) | 2.13 | 0.0 | 1e-06 |
GO:0006753 | nucleoside phosphate metabolic process | 8.64% (7/81) | 4.38 | 0.0 | 1e-06 |
GO:0034641 | cellular nitrogen compound metabolic process | 24.69% (20/81) | 2.01 | 0.0 | 1e-06 |
GO:0044237 | cellular metabolic process | 32.1% (26/81) | 1.61 | 0.0 | 2e-06 |
GO:0009152 | purine ribonucleotide biosynthetic process | 6.17% (5/81) | 5.21 | 0.0 | 2e-06 |
GO:0046390 | ribose phosphate biosynthetic process | 6.17% (5/81) | 5.21 | 0.0 | 2e-06 |
GO:0009260 | ribonucleotide biosynthetic process | 6.17% (5/81) | 5.21 | 0.0 | 2e-06 |
GO:0090407 | organophosphate biosynthetic process | 8.64% (7/81) | 3.89 | 0.0 | 5e-06 |
GO:0044281 | small molecule metabolic process | 13.58% (11/81) | 2.7 | 1e-06 | 1e-05 |
GO:0009259 | ribonucleotide metabolic process | 6.17% (5/81) | 4.63 | 1e-06 | 1.5e-05 |
GO:0019693 | ribose phosphate metabolic process | 6.17% (5/81) | 4.63 | 1e-06 | 1.5e-05 |
GO:0009150 | purine ribonucleotide metabolic process | 6.17% (5/81) | 4.63 | 1e-06 | 1.5e-05 |
GO:1901135 | carbohydrate derivative metabolic process | 8.64% (7/81) | 3.57 | 2e-06 | 1.9e-05 |
GO:0019637 | organophosphate metabolic process | 8.64% (7/81) | 3.29 | 7e-06 | 6.8e-05 |
GO:1901137 | carbohydrate derivative biosynthetic process | 6.17% (5/81) | 4.04 | 1.1e-05 | 0.00011 |
GO:0008173 | RNA methyltransferase activity | 3.7% (3/81) | 5.89 | 1.1e-05 | 0.000111 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 12.35% (10/81) | 2.34 | 2.5e-05 | 0.000229 |
GO:0006807 | nitrogen compound metabolic process | 25.93% (21/81) | 1.39 | 2.7e-05 | 0.000247 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0009123 | nucleoside monophosphate metabolic process | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0006414 | translational elongation | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2.47% (2/81) | 6.89 | 7e-05 | 0.000466 |
GO:0006396 | RNA processing | 7.41% (6/81) | 3.16 | 5.4e-05 | 0.000472 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0006754 | ATP biosynthetic process | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0015985 | energy coupled proton transport, down electrochemical gradient | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0015986 | ATP synthesis coupled proton transport | 3.7% (3/81) | 5.02 | 9e-05 | 0.000476 |
GO:0019438 | aromatic compound biosynthetic process | 12.35% (10/81) | 2.19 | 6.1e-05 | 0.000514 |
GO:0018130 | heterocycle biosynthetic process | 12.35% (10/81) | 2.14 | 8e-05 | 0.000524 |
GO:1901566 | organonitrogen compound biosynthetic process | 9.88% (8/81) | 2.45 | 0.000102 | 0.000528 |
GO:0006400 | tRNA modification | 3.7% (3/81) | 5.16 | 6.6e-05 | 0.000546 |
GO:0044249 | cellular biosynthetic process | 16.05% (13/81) | 1.78 | 9e-05 | 0.000573 |
GO:0006413 | translational initiation | 3.7% (3/81) | 4.89 | 0.00012 | 0.00061 |
GO:1901362 | organic cyclic compound biosynthetic process | 12.35% (10/81) | 2.06 | 0.000126 | 0.000633 |
GO:0009141 | nucleoside triphosphate metabolic process | 3.7% (3/81) | 4.78 | 0.000155 | 0.000763 |
GO:1901576 | organic substance biosynthetic process | 16.05% (13/81) | 1.7 | 0.000158 | 0.000766 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 13.58% (11/81) | 1.88 | 0.000176 | 0.000843 |
GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism | 2.47% (2/81) | 6.31 | 0.000209 | 0.00094 |
GO:0015252 | proton channel activity | 2.47% (2/81) | 6.31 | 0.000209 | 0.00094 |
GO:0003746 | translation elongation factor activity | 2.47% (2/81) | 6.31 | 0.000209 | 0.00094 |
GO:0016741 | transferase activity, transferring one-carbon groups | 6.17% (5/81) | 3.19 | 0.000208 | 0.000977 |
GO:1901657 | glycosyl compound metabolic process | 3.7% (3/81) | 4.57 | 0.000243 | 0.001062 |
GO:0009116 | nucleoside metabolic process | 3.7% (3/81) | 4.57 | 0.000243 | 0.001062 |
GO:0071704 | organic substance metabolic process | 28.4% (23/81) | 1.07 | 0.000326 | 0.001406 |
GO:0003676 | nucleic acid binding | 16.05% (13/81) | 1.58 | 0.000354 | 0.001503 |
GO:0016070 | RNA metabolic process | 12.35% (10/81) | 1.86 | 0.000404 | 0.001693 |
GO:0005261 | cation channel activity | 2.47% (2/81) | 5.89 | 0.000415 | 0.001695 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 2.47% (2/81) | 5.89 | 0.000415 | 0.001695 |
GO:0046034 | ATP metabolic process | 3.7% (3/81) | 4.31 | 0.000428 | 0.001701 |
GO:0009451 | RNA modification | 3.7% (3/81) | 4.31 | 0.000428 | 0.001701 |
GO:0008152 | metabolic process | 35.8% (29/81) | 0.87 | 0.000447 | 0.001753 |
GO:0009058 | biosynthetic process | 16.05% (13/81) | 1.54 | 0.000457 | 0.001769 |
GO:0001882 | nucleoside binding | 6.17% (5/81) | 2.89 | 0.000547 | 0.001925 |
GO:0001883 | purine nucleoside binding | 6.17% (5/81) | 2.89 | 0.000547 | 0.001925 |
GO:0005525 | GTP binding | 6.17% (5/81) | 2.89 | 0.000547 | 0.001925 |
GO:0032549 | ribonucleoside binding | 6.17% (5/81) | 2.89 | 0.000547 | 0.001925 |
GO:0032550 | purine ribonucleoside binding | 6.17% (5/81) | 2.89 | 0.000547 | 0.001925 |
GO:0032561 | guanyl ribonucleotide binding | 6.17% (5/81) | 2.89 | 0.000547 | 0.001925 |
GO:0097159 | organic cyclic compound binding | 27.16% (22/81) | 1.06 | 0.000517 | 0.001954 |
GO:1901363 | heterocyclic compound binding | 27.16% (22/81) | 1.06 | 0.000517 | 0.001954 |
GO:0019001 | guanyl nucleotide binding | 6.17% (5/81) | 2.84 | 0.000648 | 0.002254 |
GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 2.47% (2/81) | 5.57 | 0.000688 | 0.00229 |
GO:0016776 | phosphotransferase activity, phosphate group as acceptor | 2.47% (2/81) | 5.57 | 0.000688 | 0.00229 |
GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors | 2.47% (2/81) | 5.57 | 0.000688 | 0.00229 |
GO:0008033 | tRNA processing | 3.7% (3/81) | 4.09 | 0.000685 | 0.002355 |
GO:0044238 | primary metabolic process | 25.93% (21/81) | 1.05 | 0.000729 | 0.002399 |
GO:1902600 | proton transmembrane transport | 3.7% (3/81) | 3.95 | 0.000901 | 0.002934 |
GO:0006399 | tRNA metabolic process | 4.94% (4/81) | 3.09 | 0.001227 | 0.003953 |
GO:0009987 | cellular process | 33.33% (27/81) | 0.83 | 0.001262 | 0.004023 |
GO:0008168 | methyltransferase activity | 4.94% (4/81) | 3.03 | 0.0014 | 0.004416 |
GO:0016763 | transferase activity, transferring pentosyl groups | 2.47% (2/81) | 5.09 | 0.00143 | 0.004465 |
GO:0015078 | proton transmembrane transporter activity | 3.7% (3/81) | 3.72 | 0.001453 | 0.00449 |
GO:0090304 | nucleic acid metabolic process | 12.35% (10/81) | 1.61 | 0.00153 | 0.004683 |
GO:0015672 | monovalent inorganic cation transport | 3.7% (3/81) | 3.67 | 0.001617 | 0.0049 |
GO:0006796 | phosphate-containing compound metabolic process | 8.64% (7/81) | 2.0 | 0.00179 | 0.005319 |
GO:0006793 | phosphorus metabolic process | 8.64% (7/81) | 2.0 | 0.00179 | 0.005319 |
GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 3.7% (3/81) | 3.52 | 0.002179 | 0.006412 |
GO:0098655 | cation transmembrane transport | 3.7% (3/81) | 3.48 | 0.00239 | 0.006835 |
GO:0098660 | inorganic ion transmembrane transport | 3.7% (3/81) | 3.48 | 0.00239 | 0.006835 |
GO:0098662 | inorganic cation transmembrane transport | 3.7% (3/81) | 3.48 | 0.00239 | 0.006835 |
GO:0005216 | ion channel activity | 2.47% (2/81) | 4.72 | 0.002425 | 0.00687 |
GO:0016740 | transferase activity | 13.58% (11/81) | 1.41 | 0.00263 | 0.007384 |
GO:1901564 | organonitrogen compound metabolic process | 14.81% (12/81) | 1.31 | 0.002957 | 0.008227 |
GO:0034660 | ncRNA metabolic process | 4.94% (4/81) | 2.72 | 0.003106 | 0.00841 |
GO:0017144 | drug metabolic process | 3.7% (3/81) | 3.35 | 0.003097 | 0.008462 |
GO:0034220 | ion transmembrane transport | 3.7% (3/81) | 3.35 | 0.003097 | 0.008462 |
GO:0032259 | methylation | 2.47% (2/81) | 4.43 | 0.003664 | 0.00975 |
GO:0034470 | ncRNA processing | 3.7% (3/81) | 3.27 | 0.003633 | 0.009752 |
GO:0022803 | passive transmembrane transporter activity | 2.47% (2/81) | 4.31 | 0.004373 | 0.011437 |
GO:0015267 | channel activity | 2.47% (2/81) | 4.31 | 0.004373 | 0.011437 |
GO:0140098 | catalytic activity, acting on RNA | 4.94% (4/81) | 2.48 | 0.005629 | 0.014599 |
GO:0003937 | IMP cyclohydrolase activity | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0004643 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0004019 | adenylosuccinate synthase activity | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0016426 | tRNA (adenine) methyltransferase activity | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:1901070 | guanosine-containing compound biosynthetic process | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0006177 | GMP biosynthetic process | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0019107 | myristoyltransferase activity | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0006188 | IMP biosynthetic process | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0046040 | IMP metabolic process | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0046037 | GMP metabolic process | 1.23% (1/81) | 6.89 | 0.008417 | 0.019513 |
GO:0003674 | molecular_function | 54.32% (44/81) | 0.42 | 0.008692 | 0.019998 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 2.47% (2/81) | 3.8 | 0.008769 | 0.020024 |
GO:0022890 | inorganic cation transmembrane transporter activity | 3.7% (3/81) | 2.72 | 0.010471 | 0.023733 |
GO:0005488 | binding | 32.1% (26/81) | 0.63 | 0.010637 | 0.023933 |
GO:0009163 | nucleoside biosynthetic process | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0034708 | methyltransferase complex | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0042455 | ribonucleoside biosynthetic process | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0031515 | tRNA (m1A) methyltransferase complex | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0030488 | tRNA methylation | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0043527 | tRNA methyltransferase complex | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0004486 | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0019238 | cyclohydrolase activity | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:1901659 | glycosyl compound biosynthetic process | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1) | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:1901068 | guanosine-containing compound metabolic process | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0046129 | purine ribonucleoside biosynthetic process | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0042451 | purine nucleoside biosynthetic process | 1.23% (1/81) | 5.89 | 0.016765 | 0.03375 |
GO:0032991 | protein-containing complex | 7.41% (6/81) | 1.53 | 0.017287 | 0.034575 |
GO:0043170 | macromolecule metabolic process | 16.05% (13/81) | 0.95 | 0.015731 | 0.035138 |
GO:0016874 | ligase activity | 3.7% (3/81) | 2.43 | 0.017979 | 0.035494 |
GO:0008324 | cation transmembrane transporter activity | 3.7% (3/81) | 2.43 | 0.017979 | 0.035494 |
GO:0015318 | inorganic molecular entity transmembrane transporter activity | 3.7% (3/81) | 2.39 | 0.019457 | 0.038165 |
GO:0006812 | cation transport | 3.7% (3/81) | 2.25 | 0.025146 | 0.047206 |
GO:0046128 | purine ribonucleoside metabolic process | 1.23% (1/81) | 5.31 | 0.025043 | 0.047303 |
GO:0009119 | ribonucleoside metabolic process | 1.23% (1/81) | 5.31 | 0.025043 | 0.047303 |
GO:0042278 | purine nucleoside metabolic process | 1.23% (1/81) | 5.31 | 0.025043 | 0.047303 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 1.23% (1/81) | 5.31 | 0.025043 | 0.047303 |
GO:0008175 | tRNA methyltransferase activity | 1.23% (1/81) | 5.31 | 0.025043 | 0.047303 |
GO:0006383 | transcription by RNA polymerase III | 1.23% (1/81) | 5.31 | 0.025043 | 0.047303 |